• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

染色体 4 的缺失与结直肠肝转移瘤 R0 切除术后的长期生存改善和较低的复发率相关。

Loss of chromosome 4 correlates with better long-term survival and lower relapse rate after R0-resection of colorectal liver metastases.

机构信息

Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Kollegiengasse 10, Postfach, 07743, Jena, Germany.

出版信息

J Cancer Res Clin Oncol. 2013 Nov;139(11):1861-7. doi: 10.1007/s00432-013-1505-2. Epub 2013 Sep 6.

DOI:10.1007/s00432-013-1505-2
PMID:24061341
Abstract

PURPOSE

Liver metastases are the major cause of cancer-related death in colorectal cancer patients with a tendency to recur in over 50 % of the cases even after curatively intended surgery. Prognosis after liver resection, however, can neither be based on macroscopic or light microscopic evaluation of the metastases nor on clinical data alone. This is a pilot study in order to determine a potential influence of chromosomal aberrations on overall survival and relapse rate after curative liver resection.

METHODS

Twenty randomly selected cases (10 patients with a survival of more and 10 patients with a survival of less than 5 years after resection) were studied by array comparative genomic hybridization.

RESULTS

The distributions concerning age, gender, stage and grading of primary tumor, percentage of patients with chemotherapy, number and distribution of the liver metastases, Nordlinger and Fong scores showed no differences between long- and short-term survivors and no correlation to any chromosomal aberration. However, the relapse rate of patients with (partial) monosomy 4 was lower and the long-time survival better than in the other patients.

CONCLUSIONS

Loss of chromosome 4 in colorectal liver metastases seems not only to be associated with the progression of the primary tumor as reported in the literature, but also with the long-term survival and the cumulative relapse rate after complete resection of colorectal liver metastases.

摘要

目的

肝转移是结直肠癌患者癌症相关死亡的主要原因,即使在根治性手术之后,仍有超过 50%的病例倾向于复发。然而,肝切除术后的预后既不能基于转移灶的宏观或光镜评估,也不能仅基于临床数据。本研究旨在确定染色体畸变对结直肠癌肝转移患者根治性切除术后总生存率和复发率的潜在影响。

方法

对 20 例随机选择的病例(10 例患者切除后生存时间超过 5 年,10 例患者切除后生存时间不足 5 年)进行了阵列比较基因组杂交分析。

结果

长期和短期存活患者在年龄、性别、肿瘤分期和分级、化疗患者比例、肝转移灶数量和分布、Nordlinger 和 Fong 评分等方面的分布无差异,且与任何染色体畸变均无相关性。然而,存在(部分)单体 4 的患者的复发率较低,长期生存率较高。

结论

结直肠肝转移中染色体 4 的缺失不仅与文献报道的原发性肿瘤的进展有关,而且与结直肠肝转移完全切除后的长期生存率和累积复发率有关。

相似文献

1
Loss of chromosome 4 correlates with better long-term survival and lower relapse rate after R0-resection of colorectal liver metastases.染色体 4 的缺失与结直肠肝转移瘤 R0 切除术后的长期生存改善和较低的复发率相关。
J Cancer Res Clin Oncol. 2013 Nov;139(11):1861-7. doi: 10.1007/s00432-013-1505-2. Epub 2013 Sep 6.
2
Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.经动脉(化疗)栓塞与全身化疗治疗结直肠癌肝转移。
Cochrane Database Syst Rev. 2024 Aug 9;8(8):CD012757. doi: 10.1002/14651858.CD012757.pub2.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.伊立替康、奥沙利铂和雷替曲塞用于治疗晚期结直肠癌:系统评价与经济学评估
Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. doi: 10.3310/hta12150.
5
Laparoscopic versus open liver resection for colorectal liver metastases: A systematic review and meta-analysis of studies with propensity score-based analysis.腹腔镜与开腹肝切除术治疗结直肠癌肝转移:基于倾向评分匹配分析的系统评价和荟萃分析。
Int J Surg. 2017 Aug;44:191-203. doi: 10.1016/j.ijsu.2017.05.073. Epub 2017 Jun 2.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
A systematic overview of chemotherapy effects in colorectal cancer.结直肠癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):282-308. doi: 10.1080/02841860151116367.
8
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
9
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial.小尺寸结直肠癌肝转移灶的热消融与手术切除对比研究(COLLISION):一项国际、随机、对照、3期非劣效性试验
Lancet Oncol. 2025 Feb;26(2):187-199. doi: 10.1016/S1470-2045(24)00660-0. Epub 2025 Jan 20.
10
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.

引用本文的文献

1
Satellite DNA Amplification in Advanced Prostate Cancer Is Largely Independent From Euchromatic and Oncogene Amplicons.晚期前列腺癌中的卫星DNA扩增在很大程度上独立于常染色质和癌基因扩增子。
J Histochem Cytochem. 2025 Mar-Apr;73(3-4):109-113. doi: 10.1369/00221554251323657. Epub 2025 Mar 17.
2
Intracellular and extracellular factors of colorectal cancer liver metastasis: a pivotal perplex to be fully elucidated.结直肠癌肝转移的细胞内和细胞外因素:一个有待充分阐明的关键难题。
Cancer Cell Int. 2022 Nov 8;22(1):341. doi: 10.1186/s12935-022-02766-w.
3
Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion.

本文引用的文献

1
Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis.结直肠癌肝转移患者化疗相关性肝损伤:系统评价和荟萃分析。
Ann Surg Oncol. 2012 Dec;19(13):4287-99. doi: 10.1245/s10434-012-2438-8. Epub 2012 Jul 6.
2
The developing clinical problem of chemotherapy-induced hepatic injury.化疗引起的肝损伤这一不断发展的临床问题。
ANZ J Surg. 2012 Jan-Feb;82(1-2):23-9. doi: 10.1111/j.1445-2197.2011.05789.x. Epub 2011 May 17.
3
Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays.
通过对p53缺失的结肠癌细胞进行基因组和转录组分析来鉴定潜在的新型耐药机制。
Arch Toxicol. 2021 Mar;95(3):959-974. doi: 10.1007/s00204-021-02979-4. Epub 2021 Jan 30.
4
Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.耐药 CEM/ADR-5000 和敏感 CCRF-CEM 白血病细胞的基因组和转录组分析,以揭示多因素多药耐药的全部复杂性。
Sci Rep. 2016 Nov 8;6:36754. doi: 10.1038/srep36754.
高密度单核苷酸多态性阵列定义的散发性结直肠癌肝转移与原发肿瘤的独特遗传特征。
Mod Pathol. 2012 Apr;25(4):590-601. doi: 10.1038/modpathol.2011.195. Epub 2012 Jan 6.
4
Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?新辅助化疗是否能揭示最初可切除的结直肠癌肝转移的疾病,从而使其无法进行手术治疗?
J Surg Oncol. 2012 Jan;105(1):55-9. doi: 10.1002/jso.22044. Epub 2011 Aug 12.
5
Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature.结直肠癌肝转移患者长期生存的预测因素:单中心研究及文献复习。
Int J Colorectal Dis. 2011 Aug;26(8):967-81. doi: 10.1007/s00384-011-1195-7. Epub 2011 May 17.
6
Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.原发性结直肠癌的特定基因组异常与肝转移有关。
BMC Cancer. 2010 Dec 2;10:662. doi: 10.1186/1471-2407-10-662.
7
Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.染色体 4q 缺失可预测 II 期结肠癌患者的预后。
Anal Cell Pathol (Amst). 2010;33(2):95-104. doi: 10.3233/ACP-CLO-2010-0531.
8
Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.新辅助化疗后切除治疗结直肠肝转移瘤的患者中,窦性阻塞综合征会损害长期预后。
Ann Surg Oncol. 2011 Feb;18(2):421-30. doi: 10.1245/s10434-010-1317-4. Epub 2010 Sep 16.
9
Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.不同检测方法对结直肠癌肝转移患者手术切除骨髓中播散肿瘤细胞的临床影响:一项前瞻性随访研究。
BMC Cancer. 2010 Apr 20;10:153. doi: 10.1186/1471-2407-10-153.
10
Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases.肿瘤标志物演变:与影像学比较评估结直肠癌肝转移患者化疗反应。
Ann Surg Oncol. 2010 Apr;17(4):1010-23. doi: 10.1245/s10434-009-0887-5. Epub 2010 Jan 6.